¼¼°èÀÇ ¹ÙÀÌ¿À¸¶Ä¿ °Ë»ç ½ÃÀå º¸°í¼­ : 2030³â±îÁöÀÇ µ¿Çâ, ¿¹Ãø, °æÀï ºÐ¼®
Biomarker Test Market Report: Trends, Forecast and Competitive Analysis to 2030
»óǰÄÚµå : 1597245
¸®¼­Ä¡»ç : Lucintel
¹ßÇàÀÏ : 2024³â 10¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 150 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,850 £Ü 5,331,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. PDF ÆÄÀÏÀº DRM(µðÁöÅÐ ÀúÀÛ±Ç °ü¸® ½Ã½ºÅÛ)ÀÌ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,439,000
PDF (2 Users License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 2¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. PDF ÆÄÀÏÀº DRM(µðÁöÅÐ ÀúÀÛ±Ç °ü¸® ½Ã½ºÅÛ)ÀÌ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,350 £Ü 7,408,000
PDF (5 Users License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. PDF ÆÄÀÏÀº DRM(µðÁöÅÐ ÀúÀÛ±Ç °ü¸® ½Ã½ºÅÛ)ÀÌ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,050 £Ü 9,762,000
PDF (Corporate License) help
PDF º¸°í¼­¸¦ ±â¾÷ ³» ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÀÌ¿ë Àοø¿¡ Á¦ÇÑÀº ¾øÀ¸³ª, ±¹³»¿¡ ÀÖ´Â »ç¾÷À常 ÇØ´çµÇ¸ç, ÇØ¿Ü ÁöÁ¡ µîÀº Æ÷ÇÔµÇÁö ¾Ê½À´Ï´Ù. PDF ÆÄÀÏÀº DRM(µðÁöÅÐ ÀúÀÛ±Ç °ü¸® ½Ã½ºÅÛ)ÀÌ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¹ÙÀÌ¿À¸¶Ä¿ °Ë»çÀÇ µ¿Çâ°ú ¿¹Ãø

¼¼°è ¹ÙÀÌ¿À¸¶Ä¿ °Ë»ç ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 12.1%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¾Ï, ½ÉÇ÷°ü, °¨¿°Áõ, ÁßÃ߽Űæ°èÀÇ °¢ ½ÃÀå¿¡¼­ÀÇ ±âȸ°¡ À¯¸Á½ÃµÇ°í ÀÖ½À´Ï´Ù.

¹ÙÀÌ¿À¸¶Ä¿ °Ë»ç ½ÃÀåÀÇ Àü·«Àû ¼ºÀå ±âȸ

¹ÙÀÌ¿À¸¶Ä¿ °Ë»ç ½ÃÀåÀº Áøº¸µÈ Áø´Ü ¹× Ä¡·á µµ±¸¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¸¦ ¹Ý¿µÇÏ¸ç ´Ù¾çÇÑ ¿ëµµ¿¡¼­ ¿©·¯ °¡Áö Àü·«Àû ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù., ¸ÂÃãÇü ÀÇ·áÀÇ ÃßÁø¿¡ ÀÇÇØ ÃÊ·¡µË´Ï´Ù.ÀÌ·¯ÇÑ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇØ, Ȱ¿ëÇÏ´Â °ÍÀ¸·Î, Å« °æÀï ¿ìÀ§¼ºÀ» ȹµæÇØ, ½ÃÀå È®´ë¸¦ µÞ¹ÞħÇÒ ¼ö ÀÖ½À´Ï´Ù.

¹ÙÀÌ¿À ¸¶Ä¿ °Ë»ç ½ÃÀåÀº ¾Ï, ½ÉÇ÷°ü Áúȯ, ½Å°æ Áúȯ, °¨¿°, ¸ÂÃãÇü ÀÇ·á µî ¿©·¯ ¾ÖÇø®ÄÉÀ̼ǿ¡ °ÉÃÄ ÀÖ½À´Ï´Ù. ¼ºÀåÀ» °¡Á®¿À´Â Áß¿äÇÑ ºÐ¾ßÀÔ´Ï´Ù. ÀÌÇØ °ü°èÀÚ´Â ÀÌ·¯ÇÑ ±âȸ¸¦ Ȱ¿ëÇÏ¸é º¸´Ù Á¤È®ÇÏ°í °³º°È­µÈ È¿°úÀûÀÎ Áø´Ü µµ±¸ °³¹ß¿¡ ±â¿©ÇÏ°í ½ÃÀå È®´ë¿Í ȯÀÚ °á°ú °³¼±À» À̲ø¾î ³¾ ¼ö ÀÖ½À´Ï´Ù., ÀÌ·¯ÇÑ ¼ºÀå ±âȸ´Â ÇコÄɾîÀÇ ¹Ì·¡¸¦ Çü¼ºÇϴµ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÑ´Ù°í »ý°¢µË´Ï´Ù.

¹ÙÀÌ¿À¸¶Ä¿ °Ë»ç ½ÃÀå ¼ºÀå ÃËÁø¿äÀΡ¤°úÁ¦

¹ÙÀÌ¿À¸¶Ä¿ °Ë»ç ½ÃÀåÀº ¼ºÀå°ú ¹ßÀüÀ» Çü¼ºÇÏ´Â ´Ù¾çÇÑ ±â¼úÀû, °æÁ¦Àû, ±ÔÁ¦Àû ¿äÀÎÀÇ ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ¿äÀÎÀº ÅõÀÚ ¹× ½ÃÀå Á¢±Ù¼º ±ÔÁ¦ ¹®Á¦´Â »õ·Î¿î ¹ÙÀÌ¿À ¸¶Ä¿ °Ë»çÀÇ ½ÂÀΰú ÀÓ»ó ÅëÇÕ¿¡ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ±×¸®°í °³¼±ÀÇ ±âȸ¸¦ ÆÄ¾ÇÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.

¹ÙÀÌ¿À¸¶Ä¿ °Ë»ç ½ÃÀåÀ» °ßÀÎÇÏ´Â ¿äÀÎÀº ´ÙÀ½°ú °°½À´Ï´Ù:

¹ÙÀÌ¿À¸¶Ä¿ °Ë»ç ½ÃÀåÀÇ °úÁ¦´Â ´ÙÀ½°ú °°´Ù:

¹ÙÀÌ¿À¸¶Ä¿ °Ë»ç ½ÃÀåÀº ±â¼ú Áøº¸, ¸ÂÃãÇü ÀÇ·á ¼ö¿ä, ¸¸¼º ÁúȯÀÇ ÀÌȯÀ² Áõ°¡, R&D ÅõÀÚ Áõ°¡, AI¿Í µ¥ÀÌÅÍ ºÐ¼®ÀÇ ÅëÇÕ µî ´Ù¾çÇÑ ÃËÁø¿äÀο¡ ÀÇÇØ Çü¼ºµË´Ï´Ù. ±×·¯³ª ½ÃÀåÀº ±ÔÁ¦ Àå¾Ö¹°, ³ôÀº °³¹ß ºñ¿ë, µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã¿¡ ´ëÇÑ ¿ì·Á¿Í °°Àº °úÁ¦¿¡µµ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿À¸¶Ä¿ °Ë»ç ½ÃÀåÀ» ¹ßÀü½ÃŰ°í °Ç°­ °ü¸® ºÐ¾ßÀÇ Áø´Ü ´É·ÂÀ» °­È­Çϱâ À§Çؼ­´Â ¼ºÀå ÃËÁø¿äÀÎÀ» Ȱ¿ëÇϸ鼭 ÀÌ·¯ÇÑ °úÁ¦¸¦ ÇØ°áÇÏ´Â °ÍÀÌ ÇʼöÀûÀÔ´Ï´Ù. ½ÃÀåÀÌ ¹ßÀüÇÔ¿¡ µû¶ó ÀÌ·¯ÇÑ ¿ä¼Ò¸¦ ¼º°øÀûÀ¸·Î ±Øº¹ÇÏ´Â °ÍÀÌ Áö¼ÓÀûÀÎ Çõ½Å°ú È®Àå¿¡ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼¼°èÀÇ ¹ÙÀÌ¿À¸¶Ä¿ °Ë»ç ½ÃÀå : ½ÃÀå ¿ªÇÐ

Á¦3Àå ½ÃÀå µ¿Çâ°ú ¿¹Ãø ºÐ¼®(2018-2030³â)

Á¦4Àå Áö¿ªº° ½ÃÀå µ¿Çâ°ú ¿¹Ãø ºÐ¼®(2018-2023³â)

Á¦5Àå °æÀï ºÐ¼®

Á¦6Àå ¼ºÀå ±âȸ¿Í Àü·« ºÐ¼®

Á¦7Àå ÁÖ¿ä ±â¾÷ÀÇ ±â¾÷ ÇÁ·ÎÆÄÀÏ

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Biomarker Test Trends and Forecast

The future of the global biomarker test market looks promising with opportunities in the cancer, cardiovascular, infectious diseases, and central nervous systems markets. The global biomarker test market is expected to grow with a CAGR of 12.1% from 2024 to 2030. The major drivers for this market are rise in cancer incidence and increasing funding in biomarker studies and technological advancement.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Biomarker Test Market

The biomarker test market is rapidly evolving, driven by technological advancements, increasing demand for precision medicine, and growing research capabilities. Emerging trends are reshaping how biomarkers are used for disease diagnosis, treatment monitoring, and personalized medicine. These trends reflect innovations in technology, shifts in clinical practices, and advancements in research that enhance the effectiveness and accessibility of biomarker tests.

The biomarker test market is experiencing significant changes driven by emerging trends such as AI and machine learning integration, advancements in liquid biopsy technologies, and the expansion of genomics and NGS. The focus on personalized and precision medicine and the increased applications of biomarkers beyond oncology are reshaping the landscape of diagnostics and therapeutic approaches. These trends reflect a broader shift towards more sophisticated, individualized, and non-invasive testing methods, promising to enhance diagnostic accuracy and treatment efficacy across various medical fields. As these trends continue to develop, they will drive further innovation and growth in the biomarker test market.

Recent Developments in the Biomarker Test Market

The biomarker test market is undergoing significant transformations, driven by technological advancements, increasing demand for personalized medicine, and evolving healthcare needs. Recent developments highlight progress in areas such as innovative testing technologies, regulatory changes, and expanded applications across various diseases. These developments are reshaping the landscape of diagnostics, offering new opportunities for early detection, precise treatment, and improved patient outcomes. Understanding these key advancements provides insight into the current state and future direction of the biomarker test market.

The biomarker test market, driven by advancements in liquid biopsy technologies, AI and machine learning integration, expansion of NGS applications, regulatory advancements, and increased focus on multi-omics approaches, is significantly impacting the field. These advancements are enhancing diagnostic accuracy, personalizing treatment strategies, and improving patient outcomes. As technology continues to evolve and regulatory environments adapt, the biomarker test market is poised for further growth and innovation, driving the future of precision medicine and personalized healthcare.

Strategic Growth Opportunities for Biomarker Test Market

The biomarker test market offers several strategic growth opportunities across various applications, reflecting the increasing demand for advanced diagnostic and therapeutic tools. These opportunities are driven by technological advancements, evolving healthcare needs, and the push for personalized medicine. Identifying and leveraging these growth opportunities can provide significant competitive advantages and support market expansion.

The biomarker test market spans multiple applications, including oncology, cardiovascular diseases, neurological disorders, infectious diseases, and personalized medicine. Each application represents a significant area of potential growth, driven by technological advancements and increasing healthcare needs. By leveraging these opportunities, stakeholders can contribute to the development of more accurate, personalized, and effective diagnostic tools, driving market expansion and improving patient outcomes. As the field of biomarker testing continues to evolve, these growth opportunities will play a crucial role in shaping the future of healthcare.

Biomarker Test Market Driver and Challenges

The biomarker test market is influenced by a variety of technological, economic, and regulatory factors that shape its growth and development. Technological advancements drive innovation and expand the applications of biomarker tests, while economic factors influence investment and market accessibility. Regulatory challenges impact the approval and integration of new biomarker tests into clinical practice. Understanding these drivers and challenges is crucial for navigating the market's dynamics and identifying opportunities for growth and improvement.

The factors responsible for driving the biomarker test market include:

Challenges in the biomarker test market are:

The biomarker test market is shaped by various drivers, including technological advancements, the demand for personalized medicine, the rising incidence of chronic diseases, increased R&D investment, and the integration of AI and data analytics. However, the market also faces challenges related to regulatory hurdles, high development costs, and data privacy concerns. Addressing these challenges while leveraging the drivers of growth is essential for advancing the biomarker test market and enhancing diagnostic capabilities in the healthcare sector. As the market evolves, navigating these factors will be crucial for sustained innovation and expansion.

List of Biomarker Test Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies biomarker test companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biomarker test companies profiled in this report include-

Biomarker Test by Segment

The study includes a forecast for the global biomarker test by application, end use, and region.

Biomarker Test Market by Application [Analysis by Value from 2018 to 2030]:

Biomarker Test Market by End Use [Analysis by Value from 2018 to 2030]:

Biomarker Test Market by Region [Analysis by Value from 2018 to 2030]:

Country Wise Outlook for the Biomarker Test Market

The biomarker test market is evolving rapidly as advancements in medical technology, increasing demand for personalized medicine, and growing investment in research and development drive innovation across various regions. Biomarkers, which are critical for diagnosing diseases, monitoring treatment responses, and predicting disease risk, are becoming increasingly sophisticated. In the United States, China, Germany, India, and Japan, recent developments reflect regional focuses on technology adoption, regulatory advancements, and healthcare needs.

Features of the Global Biomarker Test Market

Market Size Estimates: Biomarker test market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Biomarker test market size by application, end use, and region in terms of value ($B).

Regional Analysis: Biomarker test market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different applications, end uses, and regions for the biomarker test market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biomarker test market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

Table of Contents

1. Executive Summary

2. Global Biomarker Test Market : Market Dynamics

3. Market Trends and Forecast Analysis from 2018 to 2030

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

5. Competitor Analysis

6. Growth Opportunities and Strategic Analysis

7. Company Profiles of Leading Players

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â